Guardant Health to Participate in Upcoming Investor Conferences
Guardant Health (Nasdaq: GH), a precision oncology company, announced its participation in three upcoming investor conferences.
These include the William Blair 44th Annual Growth Stock Conference in Chicago on June 4, the Jefferies Global Healthcare Conference in New York on June 5, and the Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 11.
Live and archived webcasts of these sessions will be available on Guardant Health's website under the 'Investors' section.
- Participation in three significant investor conferences indicates active engagement with investors.
- Scheduled presentations at well-known conferences could enhance visibility and reputation among investors.
- Webcasts provide broader accessibility for potential investors unable to attend in person.
- No specific financial or clinical data was provided in the announcement to gauge recent performance.
- Absence of details on any new developments or product updates may concern investors looking for more substantial news.
- Potential risk of over-reliance on conferences to drive investor interest without concrete updates.
-
William Blair 44th Annual Growth Stock Conference in
Chicago
Presentation on Tuesday, June 4 at 3:20 p.m. CT / 4:20 p.m. ET
-
Jefferies Global Healthcare Conference in
New York
Presentation on Wednesday, June 5 at 5:00 p.m. ET / 2:00 p.m. PT
-
Goldman Sachs 45th Annual Global Healthcare Conference in
Miami Beach, Florida
Fireside chat on Tuesday, June 11 at 2:00 p.m. ET / 11:00 a.m. PT
Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240522599294/en/
Investor Contact:
investors@guardanthealth.com
Media Contact:
Melissa Marasco
press@guardanthealth.com
+1 650-647-3711
Source: Guardant Health, Inc.
FAQ
When will Guardant Health present at the William Blair 44th Annual Growth Stock Conference?
What is the date and time of Guardant Health's presentation at the Jefferies Global Healthcare Conference?
When is Guardant Health's fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference?